Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients. With our team of seasoned scientists, entrepreneurs and investment professionals we build great companies to save patients’ lives. More information can be found on www.droiaventures.com.
